{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:39:24Z","timestamp":1792550364500,"version":"4.5.0"},"reference-count":297,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007933","name":"Liaoning University","doi-asserted-by":"publisher","award":["2025-MSLH-310"],"award-info":[{"award-number":["2025-MSLH-310"]}],"id":[{"id":"10.13039\/501100007933","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005085","name":"Beijing Institute of Technology","doi-asserted-by":"publisher","award":["2244103"],"award-info":[{"award-number":["2244103"]}],"id":[{"id":"10.13039\/501100005085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007567","name":"City University of Hong Kong","doi-asserted-by":"publisher","award":["JRFS2526-4S03"],"award-info":[{"award-number":["JRFS2526-4S03"]}],"id":[{"id":"10.13039\/100007567","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jconrel.2026.115245","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:48:55Z","timestamp":1786463335000},"page":"115245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["STING-targeted nanomedicine in combination cancer immunotherapy: From rational design to formulation engineering to clinical translation"],"prefix":"10.1016","volume":"398","author":[{"given":"Na","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115245_bb0005","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.3390\/biomedicines13092160","article-title":"STING-activating nanoparticles combined with PD-1\/PD-L1 blockade: a synergistic approach in cancer immunotherapy","volume":"13","author":"Bartusik-Aebisher","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2026.115245_bb0010","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","article-title":"Non-cell-autonomous cancer progression from chromosomal instability","volume":"620","author":"Li","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115245_bb0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","article-title":"Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced\/metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib study","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-025-02366-y","article-title":"Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy","volume":"24","author":"Zeng","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.115245_bb0025","first-page":"1","article-title":"Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy","volume":"16","author":"Zheng","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115245_bb0030","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1021\/acs.accounts.0c00475","article-title":"Nano-immune-engineering approaches to advance cancer immunotherapy: lessons from ultra-pH-sensitive nanoparticles","volume":"53","author":"Li","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303149","article-title":"Bioactivable STING nanoagonists to synergize NIR-II mild photothermal therapy primed robust and long-term anticancer immunity","volume":"35","author":"Ma","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115245_bb0040","doi-asserted-by":"crossref","DOI":"10.1172\/JCI192397","article-title":"Targeting STING-induced immune evasion with nanoparticulate binary pharmacology improves tumor control in mice","volume":"135","author":"Meng","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115245_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aeb0452","article-title":"Dual-receptor targeting of type I conventional dendritic cells with DNA-scaffolded nanoparticles enhances STING-licensed antitumor immunity","volume":"12","author":"Jana","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115245_bb0050","article-title":"Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: a comprehensive review of strategies and future perspectives","volume":"23","author":"Huang","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115245_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1258691","article-title":"Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma","volume":"14","author":"Hajiabadi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0060","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1084\/jem.20182192","article-title":"STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death","volume":"216","author":"Wu","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115245_bb0065","article-title":"Precision targeting of STING: challenges, innovations, and clinical outlook for cancer therapy","volume":"7","author":"Shi","year":"2026","journal-title":"Innovation"},{"key":"10.1016\/j.jconrel.2026.115245_bb0070","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.3390\/ijms24044128","article-title":"STING agonist-induced skin inflammation is exacerbated with prior systemic innate immune activation","volume":"24","author":"Pyclik","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0075","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Emerging cGAS-STING agonist-based nanotherapeutics: mechanistic insights and applications in cancer combination therapy","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0080","article-title":"Temporally programmed STING nanoadjuvant delivery enhances chemoimmunotherapy, driving durable tumor control with reduced toxicity","volume":"11","author":"Yang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115245_bb0085","article-title":"Sequential release HydroLipo system for STING gene epigenetic reprogramming and immune activation in glioblastoma","volume":"12","author":"Yu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0090","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/s41467-025-56407-7","article-title":"Cascaded immunotherapy with implantable dual-drug depots sequentially releasing STING agonists and apoptosis inducers","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115245_bb0095","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0100","doi-asserted-by":"crossref","first-page":"R730","DOI":"10.1016\/j.cub.2022.05.027","article-title":"cGAS\u2013STING signaling","volume":"32","author":"Sun","year":"2022","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0105","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.ymthe.2023.03.026","article-title":"Biomaterial-enabled therapeutic modulation of cGAS-STING signaling for enhancing antitumor immunity","volume":"31","author":"Liu","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115245_bb0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.immuni.2020.05.013","article-title":"Structures and mechanisms in the cGAS-STING innate immunity pathway","volume":"53","author":"Zhang","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115245_bb0115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12943-025-02495-4","article-title":"Context-dependent impact of type I interferon signaling in cancer","volume":"24","author":"Ruiz-Iglesias","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.115245_bb0120","doi-asserted-by":"crossref","first-page":"E4306","DOI":"10.1073\/pnas.1503831112","article-title":"Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses","volume":"112","author":"Ma","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115245_bb0125","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.4049\/jimmunol.1101313","article-title":"Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing","volume":"188","author":"Simmons","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.immuni.2014.12.015","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"42","author":"Woo","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115245_bb0135","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1158\/2326-6066.CIR-18-0403","article-title":"Sustained Type I interferon reinforces NK cell\u2013mediated cancer immunosurveillance during chronic virus infection","volume":"7","author":"Oh","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb0140","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","article-title":"Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy","volume":"122","author":"Garland","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115245_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add1153","article-title":"STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy","volume":"8","author":"Wang-Bishop","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0150","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1172\/JCI125413","article-title":"STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade","volume":"129","author":"Yang","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115245_bb0155","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jconrel.2021.01.036","article-title":"Maintaining manganese in tumor to activate cGAS-STING pathway evokes a robust abscopal anti-tumor effect","volume":"331","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb0160","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.7150\/thno.58390","article-title":"Turning cold tumors into hot tumors by improving T-cell infiltration","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115245_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584626","article-title":"Regulation of PD-L1 expression by NF-\u03baB in cancer","volume":"11","author":"Antonangeli","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0170","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112258118","article-title":"PD-L1 sustains chronic, cancer cell\u2013intrinsic responses to type I interferon, enhancing resistance to DNA damage","volume":"118","author":"Cheon","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115245_bb0175","article-title":"Silencing PCSK9 reshapes the spatiotemporal activation of STING for safe and effective cancer immunotherapy","volume":"11622","author":"Sun","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115245_bb0180","article-title":"B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8+ T-cell exhaustion in non-small cell lung cancer","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0185","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s10238-025-01838-1","article-title":"Unlocking the therapeutic potential of the STING signaling pathway in anti-tumor treatment","volume":"25","author":"Li","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115245_bb0190","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41586-025-09539-1","article-title":"Proteotoxic stress response drives T cell exhaustion and immune evasion","volume":"647","author":"Wang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115245_bb0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40364-023-00551-z","article-title":"Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy","volume":"12","author":"Chen","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb0200","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide\u2013manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0205","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41565-022-01225-x","article-title":"Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration","volume":"17","author":"Yang","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0210","article-title":"Acid-ionizable iron nanoadjuvant augments STING activation for personalized vaccination immunotherapy of cancer","volume":"35","author":"Chen","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115245_bb0215","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/nano9040638","article-title":"Lipid-based nanoparticles: application and recent advances in cancer treatment","volume":"9","author":"Garc\u00eda-Pinel","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2026.115245_bb0220","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1124\/pr.115.012070","article-title":"Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come","volume":"68","author":"Yingchoncharoen","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2026.115245_bb0225","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jphotobiol.2016.09.013","article-title":"An overview of drug delivery vehicles for cancer treatment: nanocarriers and nanoparticles including photovoltaic nanoparticles","volume":"164","author":"Chowdhury","year":"2016","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.jconrel.2026.115245_bb0230","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3762\/bjnano.15.131","article-title":"Mechanistic insights into endosomal escape by sodium oleate-modified liposomes","volume":"15","author":"Sadaqa","year":"2024","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0235","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1021\/acsnano.2c02347","article-title":"Surface modification of lipid-based nanoparticles","volume":"16","author":"Xu","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202401990","article-title":"Surface engineering of lipid-based drug delivery systems","volume":"20","author":"Patel","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115245_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002852","article-title":"STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation","volume":"9","author":"Nakamura","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115245_bb0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13045-019-0833-3","article-title":"Nanotechnology in cancer diagnosis: progress, challenges and opportunities","volume":"12","author":"Zhang","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0255","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/jps.21176","article-title":"Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms","volume":"97","author":"Houchin","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129434","article-title":"Emerging natural polymer-based architectured nanotherapeutics for the treatment of cancer","volume":"262","author":"Kuna","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0265","article-title":"Functional dendrimer nanogels for DNA delivery and gene therapy of tumors","volume":"64","author":"Li","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115245_bb0270","article-title":"Sprayed aqueous microdroplets for spontaneous synthesis of functional microgels","volume":"64","author":"Li","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115245_bb0275","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/acsnano.8b05151","article-title":"Super-resolution imaging of proton sponge-triggered rupture of endosomes and cytosolic release of small interfering RNA","volume":"13","author":"Wojnilowicz","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb0280","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/polym10010031","article-title":"Polymer-based nanomaterials and applications for vaccines and drugs","volume":"10","author":"Han","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2026.115245_bb0285","first-page":"057","article-title":"Polymer-based nanoparticles in targeted cancer therapy: a review","volume":"14","author":"Al-Sahlawi","year":"2024","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0290","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1039\/C9TB01222B","article-title":"Nucleic acids presenting polymer nanomaterials as vaccine adjuvants","volume":"7","author":"Comberlato","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2026.115245_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202409021","article-title":"Advances in polymer-based self-adjuvanted nanovaccines","volume":"21","author":"Ling","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115245_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125757","article-title":"A nanoparticle platform for the co-delivery of multiple antigen epitope peptides and STING agonist to lymph nodes for cancer immunotherapy","volume":"680","author":"Ke","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115245_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.chempr.2025.102624","article-title":"Protein-based nanomedicines for cancer theranostics: from supramolecular self-assembly to AI-driven design and applications","author":"Cheng","year":"2025","journal-title":"Chem"},{"key":"10.1016\/j.jconrel.2026.115245_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2024.216142","article-title":"Photodynamic and photothermal therapy via human serum albumin delivery","volume":"520","author":"Li","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115245_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2020.213258","article-title":"Nano theranostics platforms that utilize proteins","volume":"412","author":"Lee","year":"2020","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115245_bb0320","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/acs.molpharmaceut.1c00046","article-title":"The uniqueness of albumin as a carrier in nanodrug delivery","volume":"18","author":"Spada","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115245_bb0325","doi-asserted-by":"crossref","first-page":"12237","DOI":"10.1021\/acsnano.5c00322","article-title":"A hybrid manganese nanoparticle simultaneously eliminates cancer stem cells and activates STING pathway to potentiate cancer immunotherapy","volume":"19","author":"Wu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb0330","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.virol.2004.05.025","article-title":"Ebola and Marburg virus-like particles activate human myeloid dendritic cells","volume":"326","author":"Bosio","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2026.115245_bb0335","doi-asserted-by":"crossref","first-page":"11825","DOI":"10.1039\/D4NR00537F","article-title":"The recent advancements in protein nanoparticles for immunotherapy","volume":"16","author":"Xu","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115245_bb0340","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11051-025-06372-5","article-title":"Protein based nanoparticles for pulmonary drug delivery: advances, challenges, and future perspectives","volume":"27","author":"Bhardwaj","year":"2025","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb0345","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jconrel.2024.02.027","article-title":"In situ bio-mineralized Mn nanoadjuvant enhances anti-influenza immunity of recombinant virus-like particle vaccines","volume":"368","author":"Sheng","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb0350","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3390\/coatings13091660","article-title":"Surface modification of metallic nanoparticles for targeting drugs","volume":"13","author":"Abdelkawi","year":"2023","journal-title":"Coatings"},{"key":"10.1016\/j.jconrel.2026.115245_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.indcrop.2025.120902","article-title":"Plant-derived paclitaxel-loaded ultra-small Fe\u2083O\u2084 nanoparticles for MR imaging-mediated antitumor therapy","volume":"228","author":"Lai","year":"2025","journal-title":"Ind. Crop. Prod."},{"key":"10.1016\/j.jconrel.2026.115245_bb0360","doi-asserted-by":"crossref","first-page":"53474","DOI":"10.1021\/acsami.4c09825","article-title":"STING agonist delivered by neutrophil membrane-coated gold nanoparticles exerts synergistic tumor inhibition with radiotherapy","volume":"16","author":"Lu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115245_bb0365","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2014.07.054","article-title":"cRGD-directed, NIR-responsive and robust AuNR\/PEG\u2013PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo","volume":"195","author":"Zhong","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115090","article-title":"The shift toward nanovaccination: a comprehensive review of advancing nanovaccination for combinatory immune regulation therapies to treat infectious diseases and cancer","volume":"161","author":"Raziq","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0375","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41392-023-01654-7","article-title":"Multifunctional mesoporous silica nanoparticles for biomedical applications","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115245_bb0380","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1039\/D4BM00094C","article-title":"In situ modified mesoporous silica nanoparticles: synthesis, properties and theranostic applications","volume":"12","author":"Trayford","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0385","doi-asserted-by":"crossref","first-page":"56741","DOI":"10.1021\/acsami.0c16728","article-title":"STING activator c-di-GMP-loaded mesoporous silica nanoparticles enhance immunotherapy against breast cancer","volume":"12","author":"Chen","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115245_bb0390","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2147\/IJN.S496873","article-title":"Enhanced cancer immunotherapy by bacterial cytoplasmic membranes coated nanovaccines for co-delivery of ovalbumin antigen and immune adjuvants to dendritic cells in lymph nodes","volume":"20","author":"Zhao","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115245_bb0395","doi-asserted-by":"crossref","first-page":"23711","DOI":"10.1021\/acsnano.4c08463","article-title":"Biodegradable long-circulating nanoagonists optimize tumor-tropism chemo-metalloimmunotherapy for boosted antitumor immunity by cascade cGAS-STING pathway activation","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102967","article-title":"Manganese in metalloimmunotherapy: from molecular targets to material engineering and translational therapeutics","volume":"67","author":"Xie","year":"2026","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115245_bb0405","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1021\/jacs.4c13241","article-title":"A second near-infrared window-responsive metal\u2013organic-framework-based photosensitizer for tumor immunotherapy via synergistic Ferroptosis and STING activation","volume":"147","author":"Zhao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115245_bb0410","doi-asserted-by":"crossref","first-page":"17470","DOI":"10.1021\/acsami.2c21005","article-title":"Transforming cold tumors into hot ones with a metal\u2013organic framework-based biomimetic nanosystem for enhanced immunotherapy","volume":"15","author":"Xu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115245_bb0415","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb0420","doi-asserted-by":"crossref","first-page":"15905","DOI":"10.1021\/acsnano.3c03962","article-title":"Manganese-based immunostimulatory metal\u2013organic framework activates the cGAS-STING pathway for cancer metalloimmunotherapy","volume":"17","author":"Zheng","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb0425","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/0122117385268268231204061938","article-title":"Emerging lipid-based carriers for systematic utilization in the pharmaceutical and biomedical sciences: a review","volume":"13","author":"Kendre","year":"2025","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0430","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.apsb.2024.06.004","article-title":"Intravenous delivery of STING agonists using acid-sensitive polycationic polymer-modified lipid nanoparticles for enhanced tumor immunotherapy","volume":"15","author":"He","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115245_bb0435","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.2147\/IJN.S462213","article-title":"Delivery of a STING agonist using lipid nanoparticles inhibits pancreatic cancer growth","volume":"19","author":"Shaji","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115245_bb0440","doi-asserted-by":"crossref","first-page":"23797","DOI":"10.1021\/acsnano.4c09094","article-title":"Modulating elasticity of liposome for enhanced cancer immunotherapy","volume":"18","author":"Yuan","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb0445","doi-asserted-by":"crossref","first-page":"994","DOI":"10.15212\/bioi-2024-0107","article-title":"Lipid-based nanoparticles: strategy for targeted cancer therapy","volume":"6","author":"Chauhan","year":"2025","journal-title":"BIO Integr."},{"key":"10.1016\/j.jconrel.2026.115245_bb0450","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1039\/D2BM01252A","article-title":"Pharmaceutical liposomal delivery \u2014 specific considerations of innovation and challenges","volume":"11","author":"Peng","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0455","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/polym17070833","article-title":"Polymeric nanoparticles in targeted drug delivery: unveiling the impact of polymer characterization and fabrication","volume":"17","author":"Eltaib","year":"2025","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2026.115245_bb0460","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41551-020-00675-9","article-title":"Prolonged activation of innate immune pathways by a polyvalent STING agonist","volume":"5","author":"Li","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115245_bb0465","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409978122","article-title":"Peptide vaccine formulations with structurally distinct STING agonist drugamers induce discrete, efficacious antitumor responses","author":"Song","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115245_bb0470","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1021\/acs.biomac.3c00630","article-title":"Self-Immolative polymer nanoparticles with precise and controllable pH-dependent degradation","volume":"24","author":"Smith","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115245_bb0475","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/polym15051123","article-title":"Polymeric nanoparticles for delivery of natural bioactive agents: recent advances and challenges","volume":"15","author":"Elmowafy","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2026.115245_bb0480","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13046-025-03544-y","article-title":"The cGAS\u2013STING pathway in colorectal cancer: bridging innate immunity and therapeutic strategies","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb0485","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41565-018-0342-5","article-title":"Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy","volume":"14","author":"Shae","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0490","article-title":"Human serum albumin as the carrier to fabricate STING-activating peptide nanovaccine for antitumor immunotherapy","volume":"25","author":"Zheng","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115245_bb0495","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s42003-021-02004-5","article-title":"ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance","volume":"4","author":"Jang","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0500","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/pharmaceutics16091216","article-title":"Targeted delivery of STING agonist via albumin nanoreactor boosts immunotherapeutic efficacy against aggressive cancers","volume":"16","author":"Miao","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115245_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42738","article-title":"Utilizing gold nanoparticles in plasmonic photothermal therapy for cancer treatment","volume":"11","author":"Badir","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.jconrel.2026.115245_bb0510","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12951-023-02235-0","article-title":"Recent trends in preparation and biomedical applications of iron oxide nanoparticles","volume":"22","author":"Meng","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0515","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1398979","article-title":"A review of metallic nanoparticles: present issues and prospects focused on the preparation methods, characterization techniques, and their theranostic applications","volume":"12","author":"Shahalaei","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.jconrel.2026.115245_bb0520","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3390\/catal11080902","article-title":"Green synthesis of metallic nanoparticles: applications and limitations","volume":"11","author":"Dikshit","year":"2021","journal-title":"Catalysts"},{"key":"10.1016\/j.jconrel.2026.115245_bb0525","article-title":"Improving STING agonist delivery for cancer immunotherapy using biodegradable mesoporous silica nanoparticles","volume":"3","author":"Park","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2026.115245_bb0530","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1007\/s13346-024-01575-0","article-title":"Immunomodulatory potential of rapamycin-loaded mesoporous silica nanoparticles: pore size-dependent drug loading, release, and in vitro cellular responses","volume":"14","author":"P\u00e9rez-Moreno","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb0535","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400323","article-title":"Mesoporous silica nanoparticles as an ideal platform for cancer immunotherapy: recent advances and future directions","volume":"13","author":"Godakhindi","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115245_bb0540","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1021\/acs.inorgchem.5c00352","article-title":"Linkage position-controlled synthesis of diverse zirconium metal\u2013organic frameworks with prominent intrinsic proton conductivities","volume":"64","author":"Yang","year":"2025","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jconrel.2026.115245_bb0545","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwae167","article-title":"STING agonist-conjugated metal-organic framework induces artificial leukocytoid structures and immune hotspots for systemic antitumor responses","volume":"11","author":"Luo","year":"2024","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.jconrel.2026.115245_bb0550","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501809","article-title":"Multiscale profiling of nanoscale metal-organic framework biocompatibility and immune interactions","volume":"14","author":"Zhuang","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115245_bb0555","article-title":"Controllable strategy of metal\u2013organic framework structural stability: regulation of ligand electronegativity by esterification","volume":"12","author":"Huang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0560","doi-asserted-by":"crossref","first-page":"30201","DOI":"10.1039\/D4RA04441J","article-title":"Metal\u2013organic frameworks in drug delivery: engineering versatile platforms for therapeutic applications","volume":"14","author":"Khafaga","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2026.115245_bb0565","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12951-025-03669-4","article-title":"Metal-organic frameworks activate the cGAS-STING pathway for cancer immunotherapy","volume":"23","author":"Zhu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0570","article-title":"Mobilizing STING pathway via a cationic liposome to enhance doxorubicin-induced antitumor immunity","volume":"35","author":"Liu","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115245_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114318","article-title":"Co-delivery of SN38 and MEF2D-siRNA via tLyp-1-modified liposomes reverses PD-L1 expression induced by STING activation in hepatocellular carcinoma","volume":"245","author":"Du","year":"2025","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2026.115245_bb0580","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1021\/jacs.4c15534","article-title":"Pyridinium rotor strategy toward a robust Photothermal agent for STING activation and multimodal image-guided immunotherapy for triple-negative breast cancer","volume":"147","author":"Ning","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115245_bb0585","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1021\/acsnano.3c04471","article-title":"A cancer nanovaccine for co-delivery of peptide neoantigens and optimized combinations of STING and TLR4 agonists","volume":"18","author":"Baljon","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb0590","doi-asserted-by":"crossref","first-page":"28973","DOI":"10.1021\/jacs.4c09831","article-title":"A type I photosensitizer-Polymersome boosts reactive oxygen species generation by forcing H-aggregation for amplifying STING immunotherapy","volume":"146","author":"Wang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115245_bb0595","doi-asserted-by":"crossref","first-page":"24219","DOI":"10.1021\/acsnano.4c05657","article-title":"Stimulator of interferon genes-activated biomimetic dendritic cell nanovaccine as a chemotherapeutic booster to enhance systemic fibrosarcoma treatment","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb0600","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41565-023-01447-7","article-title":"Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles","volume":"18","author":"Dosta","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0605","article-title":"Self-assembled albumin nanoparticles induce pyroptosis for photodynamic\/photothermal\/immuno synergistic therapies in triple-negative breast cancer","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0610","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jconrel.2024.09.023","article-title":"Albumin-based co-loaded sonosensitizer and STING agonist nanodelivery system for enhanced sonodynamic and immune combination antitumor therapy","volume":"375","author":"Huang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb0615","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn6612","article-title":"Selective STING stimulation in dendritic cells primes antitumor T cell responses","volume":"8","author":"Jneid","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2020.109311","article-title":"Combining photothermal ablation-based vaccine with immune checkpoint blockade for synergistic osteosarcoma immunotherapy","volume":"198","author":"Zhao","year":"2021","journal-title":"Mater. Des."},{"key":"10.1016\/j.jconrel.2026.115245_bb0625","article-title":"Silver molybdate nanoparticles for enhanced tumor immunotherapy through pyroptosis conversion and ferroptosis induction","volume":"64","author":"Chen","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115245_bb0630","article-title":"Synergistic glutathione depletion and STING activation to potentiate dendritic cell maturation and cancer vaccine efficacy","volume":"63","author":"Liu","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115245_bb0635","doi-asserted-by":"crossref","first-page":"15588","DOI":"10.1021\/acs.nanolett.4c03846","article-title":"STING nanoagonist boosts antitumor immunity of therapeutic DNA vaccines","volume":"24","author":"Jia","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115245_bb0640","doi-asserted-by":"crossref","first-page":"40129","DOI":"10.1021\/acsami.5c07234","article-title":"A self-amplifying MOF nanoplatform for cancer immunotherapy synergizing starvation-enhanced cuproptosis and cGAS\u2013STING activation","volume":"17","author":"Zhang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115245_bb0645","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.2147\/IJN.S477026","article-title":"Progress of nanomaterials based on manganese dioxide in the field of tumor diagnosis and therapy","volume":"19","author":"Liang","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115245_bb0650","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1038\/s41467-022-33301-0","article-title":"A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115245_bb0655","article-title":"Bimetallic nanoreactor activates cGAS-STING pathway via mtDNA release for cancer metalloimmunotherapy","volume":"36","author":"Mo","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115245_bb0660","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1021\/acsami.6b15185","article-title":"Formation of gold nanostar-coated hollow mesoporous silica for tumor multimodality imaging and photothermal therapy","volume":"9","author":"Li","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115245_bb0665","article-title":"Dual-targeted manganese-doped carbon dots activate the cGAS\u2013STING pathway and immunogenic cell death for potent glioblastoma immunotherapy","volume":"38","author":"Li","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115245_bb0670","first-page":"184","article-title":"Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunity","volume":"1","author":"Carozza","year":"2020","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2026.115245_bb0675","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202308131","article-title":"Tumor exosomal ENPP1 hydrolyzes cGAMP to inhibit cGAS-STING signaling","volume":"11","author":"An","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0680","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115245_bb0685","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41388-024-03248-1","article-title":"Tissue factor promotes TREX1 protein stability to evade cGAS-STING innate immune response in pancreatic ductal adenocarcinoma","volume":"44","author":"Xue","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2026.115245_bb0690","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1021\/acs.nanolett.9b04094","article-title":"Synthetic immunogenic cell death mediated by intracellular delivery of STING agonist nanoshells enhances anticancer chemo-immunotherapy","volume":"20","author":"Chattopadhyay","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115245_bb0695","doi-asserted-by":"crossref","DOI":"10.3390\/jfb17060308","article-title":"Zinc-doped calcium phosphate nanoagonists amplifies cGAS-STING signaling for boosting pyroptosis-induced cancer immunotherapy","volume":"17","author":"Yang","year":"2026","journal-title":"J. Function. Biomater."},{"key":"10.1016\/j.jconrel.2026.115245_bb0700","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12943-024-02186-6","article-title":"Nanomedicines harnessing cGAS-STING pathway: sparking immune revitalization to transform \u2018cold\u2019 tumors into \u2018hot\u2019 tumors","volume":"23","author":"Ying","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.115245_bb0705","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41563-022-01251-z","article-title":"STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity","volume":"21","author":"Dane","year":"2022","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115245_bb0710","doi-asserted-by":"crossref","first-page":"29942","DOI":"10.1021\/acsnano.4c10673","article-title":"Single-dose physically cross-linked hyaluronic acid and lipid hybrid nanoparticles containing cyclic guanosine monophosphate\u2013adenosine monophosphate eliminate established tumors","volume":"18","author":"Yu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb0715","article-title":"Size-dependent EPR effect of polymeric nanoparticles on tumor targeting","volume":"9","author":"Kang","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115245_bb0720","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/nmat4718","article-title":"Mechanism of hard-nanomaterial clearance by the liver","volume":"15","author":"Tsoi","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115245_bb0725","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115245_bb0730","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/pharmaceutics15020638","article-title":"Liposomal delivery of MIW815 (ADU-S100) for potentiated STING activation","volume":"15","author":"Ji","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115245_bb0735","doi-asserted-by":"crossref","first-page":"8649","DOI":"10.3390\/ijms26178649","article-title":"A study on the efficacy and pharmacological mechanism of liposome complexes containing STING agonist and anti-PD-L1 nanobody in inhibiting HCC","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114013","article-title":"Application of nanoparticles with activating STING pathway function in tumor synergistic therapy","volume":"148","author":"Yang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0745","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.3390\/molecules28093740","article-title":"Anticancer effect of STING agonist-encapsulated liposomes on breast cancer","volume":"28","author":"Zhang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2026.115245_bb0750","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3390\/pharmaceutics14091883","article-title":"Synthesis, formulation and characterization of immunotherapeutic glycosylated dendrimer\/cGAMP complexes for CD206 targeted delivery to M2 macrophages in cold tumors","volume":"14","author":"Petrovic","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115245_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.113760","article-title":"Hepatotoxicity evaluations of different surface charged carbon quantum dots in vivo and in vitro","volume":"234","author":"Chen","year":"2024","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2026.115245_bb0760","article-title":"pH-responsive STING-activating DNA nanovaccines for cancer immunotherapy","volume":"3","author":"Zhang","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2026.115245_bb0765","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202502788","article-title":"Physiological pH transition-driven protein corona dynamics regulate cellular uptake and inflammatory responses of silica nanoparticles","volume":"12","author":"Ge","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0770","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12951-021-01221-8","article-title":"Charge reversal nano-systems for tumor therapy","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0775","article-title":"Cyano-modulated Zn(II)-Schiff base complexes for lysosome-targeted fluorescence imaging and pH-responsive camptothecin delivery","volume":"12","author":"Zhang","year":"2026","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.jconrel.2026.115245_bb0780","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3762\/bjnano.17.10","article-title":"From shield to spear: charge-reversible nanocarriers in overcoming cancer therapy barriers","volume":"17","author":"Yeduvaka","year":"2026","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0785","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.4049\/jimmunol.1700972","article-title":"Innate immune activation by cGMP-AMP nanoparticles leads to potent and long-acting antiretroviral response against HIV-1","volume":"199","author":"Aroh","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0790","first-page":"2192","article-title":"Matrix Metalloproteinase-9-responsive surface charge-reversible nanocarrier to enhance endocytosis as efficient targeted delivery system for cancer diagnosis and therapy","volume":"10","author":"Han","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115245_bb0795","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1089\/ten.teb.2020.0253","article-title":"Biomaterials-driven sterile inflammation","volume":"28","author":"Chen","year":"2022","journal-title":"Tissue Eng. Part B Rev."},{"key":"10.1016\/j.jconrel.2026.115245_bb0800","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.2147\/IJN.S443168","article-title":"Long-term accumulation, biological effects and toxicity of BSA-coated gold nanoparticles in the mouse liver, spleen, and kidneys","volume":"19","author":"Jakic","year":"2024","journal-title":"Int. J. Nanomed"},{"key":"10.1016\/j.jconrel.2026.115245_bb0805","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2021.09.033","article-title":"Considerations for the delivery of STING ligands in cancer immunotherapy","volume":"339","author":"Petrovic","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb0810","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6606","article-title":"Engineered PLGA microparticles forlong-term, pulsatile release of STING agonist for cancer immunotherapy","volume":"12","author":"Lu","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115245_bb0815","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/acs.bioconjchem.8b00799","article-title":"Endosomal escape and cytosolic penetration of macromolecules mediated by synthetic delivery agents","volume":"30","author":"Brock","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.115245_bb0820","article-title":"A dual-STING-activating nanosystem expands cancer immunotherapeutic temporal window","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jconrel.2026.115245_bb0825","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1346756","article-title":"Targeted intracellular delivery of dimeric STINGa by two pHLIP peptides for treatment of solid tumors","volume":"15","author":"Moshnikova","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0830","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/s41467-023-39607-x","article-title":"Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115245_bb0835","article-title":"Tailored Nanogel network topology enables clinical ultrasound-induced mechanochemical activation for in vivo therapy","volume":"65","author":"Li","year":"2026","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115245_bb0840","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr1728","article-title":"Tumor-targeting nanocarriers amplified immunotherapy of cold tumors by STING activation and inhibiting immune evasion","volume":"11","author":"Zhao","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115245_bb0845","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41467-023-37328-9","article-title":"STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115245_bb0850","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1093240","article-title":"Nanomedicines targeting activation of STING to reshape tumor immune microenvironment and enhance immunotherapeutic efficacy","volume":"12","author":"Chen","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0855","article-title":"Transvascular transport of nanocarriers for tumor delivery","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115245_bb0860","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1021\/acscentsci.4c00579","article-title":"STING-activating polymer\u2013drug conjugates for cancer immunotherapy","volume":"10","author":"Sheehy","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0865","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jconrel.2023.05.032","article-title":"Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: a review","volume":"359","author":"Beishenaliev","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb0870","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwad214","article-title":"STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy","volume":"10","author":"Zhou","year":"2023","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.jconrel.2026.115245_bb0875","doi-asserted-by":"crossref","first-page":"0071","DOI":"10.1042\/EBC20253008","article-title":"Emerging strategies in lymph node-targeted nano-delivery systems for tumor immunotherapy","volume":"69","author":"Zhao","year":"2025","journal-title":"Essays Biochem."},{"key":"10.1016\/j.jconrel.2026.115245_bb0880","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1007\/s00018-021-03842-6","article-title":"Nanoparticle-based approaches to target the lymphatic system for antitumor treatment","volume":"78","author":"Peng","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0885","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41551-024-01208-4","article-title":"Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers","volume":"9","author":"Yin","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115245_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113846","article-title":"Nano-immunomodulator amplifies STING activation in tumor-associated macrophages for cancer immunotherapy","volume":"383","author":"Liang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb0895","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s40425-019-0807-6","article-title":"Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples","volume":"7","author":"Scott","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115245_bb0900","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1073\/pnas.1019547108","article-title":"Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A","volume":"108","author":"Idoyaga","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115245_bb0905","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14145075","article-title":"PET and SPECT imaging of macrophages in the tumor stroma: an update","volume":"14","author":"Li","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2026.115245_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101375","article-title":"Achieving dendritic cell subset-specific targeting in vivo by site-directed conjugation of targeting antibodies to nanocarriers","volume":"43","author":"Simon","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115245_bb0915","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2023.1281066","article-title":"Mannose-functionalization of reconstituted high-density lipoprotein nanoparticles improves payload delivery and enhances M2-to-M1 phenotype reprogramming of RAW 264.7 macrophages polarized by B16-F10 melanoma cells","volume":"3","author":"Dossou","year":"2023","journal-title":"Front. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115245_bb0920","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.2147\/IJN.S535460","article-title":"Nanomaterials application for STING pathway-based tumor immunotherapy","volume":"20","author":"Zhao","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115245_bb0925","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1002\/mco2.70337","article-title":"Nanocarrier-based systems for targeted delivery: current challenges and future directions","volume":"6","author":"Xu","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.jconrel.2026.115245_bb0930","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1039\/D2CS00998F","article-title":"\u2018Passive\u2019 nanoparticles for organ-selective systemic delivery: design, mechanism and perspective","volume":"52","author":"Fu","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.115245_bb0935","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pharmthera.2019.04.008","article-title":"Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates","volume":"200","author":"Mahalingaiah","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115245_bb0940","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/acs.molpharmaceut.4c01177","article-title":"Expression-dependent tumor pretargeting via engineered avidity","volume":"22","author":"Harthorn","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115245_bb0945","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12951-025-03536-2","article-title":"An imaging-guided self-amplifying photo-immunotherapeutic nanoparticle for STING pathway activation and enhanced cancer therapy","volume":"23","author":"Chen","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb0950","doi-asserted-by":"crossref","first-page":"15499","DOI":"10.1021\/acsnano.4c00063","article-title":"Delivery of mRNA encoding Interleukin-12 and a stimulator of interferon genes agonist potentiates antitumor efficacy through reversing T cell exhaustion","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb0955","article-title":"Drug-loaded bispecific T cell nanoengager overcomes T cell exhaustion for potent cancer immunotherapy","volume":"122","author":"Wang","year":"2026","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115245_bb0960","doi-asserted-by":"crossref","first-page":"12805","DOI":"10.2147\/IJN.S543991","article-title":"Nanodelivery strategies for STING agonists: toward efficient cancer immunotherapy","volume":"20","author":"Zhang","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115245_bb0965","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1021\/acsami.5c20468","article-title":"Protein nanovaccines co-delivering STING agonists for enhanced dendritic cell activation and antitumor immunity","volume":"18","author":"Yang","year":"2026","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115245_bb0970","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003960","article-title":"Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy","volume":"10","author":"Jiang","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115245_bb0975","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1021\/acs.nanolett.1c03243","article-title":"Engineered nanovaccine targeting Clec9a+ dendritic cells remarkably enhances the cancer immunotherapy effects of STING agonist","volume":"21","author":"Gou","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115245_bb0980","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/acscentsci.3c01310","article-title":"Mannosylated STING agonist drugamers for dendritic cell-mediated cancer immunotherapy","volume":"10","author":"Nguyen","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb0985","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jconrel.2022.03.054","article-title":"Systemic nano-delivery of low-dose STING agonist targeted to CD103+ dendritic cells for cancer immunotherapy","volume":"345","author":"Doshi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb0990","doi-asserted-by":"crossref","first-page":"23889","DOI":"10.1021\/acsnano.3c08174","article-title":"Manganese dioxide-entrapping dendrimers co-deliver protein and nucleotide for magnetic resonance imaging-guided chemodynamic\/starvation\/immune therapy of tumors","volume":"17","author":"Gao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb0995","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41568-024-00699-2","article-title":"Exploiting temporal aspects of cancer immunotherapy","volume":"24","author":"Zemek","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115245_bb1000","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41419-024-07283-4","article-title":"NIR-715 photodynamic therapy induces immunogenic cancer cell death by enhancing the endoplasmic reticulum stress response","volume":"15","author":"Zheng","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.115245_bb1005","doi-asserted-by":"crossref","first-page":"29224","DOI":"10.1021\/acsami.5c03172","article-title":"Homologous-targeting porous type I\/II Nanophotosensitizers for efficient delivery of STING agonists and enhanced photodynamic cancer immunotherapy","volume":"17","author":"Dutta","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115245_bb1010","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.7150\/thno.107774","article-title":"Photoactivatable immunomodulator polyprodrugs for boosting synergistic antitumor immunity of STING agonists and IDO inhibitors","volume":"15","author":"Huang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115245_bb1015","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409978122","article-title":"Peptide vaccine formulations with structurally distinct STING agonist drugamers induce discrete, efficacious antitumor responses","volume":"122","author":"Song","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115245_bb1020","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ccell.2025.02.014","article-title":"Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy","volume":"43","author":"Song","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115245_bb1025","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jconrel.2020.11.017","article-title":"Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration","volume":"330","author":"Wehbe","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb1030","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.3390\/ijms26189008","article-title":"STINGing Cancer: development, clinical application, and targeted delivery of STING agonists","volume":"26","author":"Nerdinger","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb1035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.795048","article-title":"The cGAS-STING pathway: a promising immunotherapy target","volume":"12","author":"Ou","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13045-022-01363-8","article-title":"Combination of oral STING agonist MSA-2 and anti-TGF-\u03b2\/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors","volume":"15","author":"Yi","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1045","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s10238-022-00878-1","article-title":"Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model","volume":"23","author":"Sokolowska","year":"2022","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115245_bb1050","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1038\/s41388-018-0581-9","article-title":"Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles","volume":"38","author":"Grabosch","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2026.115245_bb1055","article-title":"CTLA-4\u2014two pathways to anti-tumour immunity?","volume":"5","author":"Ward","year":"2025","journal-title":"Immunother. Adv."},{"key":"10.1016\/j.jconrel.2026.115245_bb1060","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.7150\/thno.107200","article-title":"pH-responsive nano-vaccine combined with anti-PD-1 antibodies for enhanced immunotherapy of breast cancer","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115245_bb1065","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jconrel.2024.03.022","article-title":"STING-activating cyclic dinucleotide-manganese nanoparticles","volume":"368","author":"Aikins","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb1070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41392-022-01252-z","article-title":"Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy","volume":"7","author":"Zhang","year":"2022","journal-title":"Sign. Transd. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115245_bb1075","article-title":"Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1344272","article-title":"Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors","volume":"15","author":"Ouyang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/ijms24010041","article-title":"Insights and strategies of melanoma immunotherapy: predictive biomarkers of response and resistance and strategies to improve response rates","volume":"24","author":"Seyhan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb1090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00262-023-03581-6","article-title":"Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma","volume":"73","author":"Versluis","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2026.115245_bb1095","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1158\/1078-0432.CCR-23-1170","article-title":"Correction: phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb1100","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb1105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122034","article-title":"Interval- and cycle-dependent combined effect of STING agonist loaded lipid nanoparticles and a PD-1 antibody","volume":"624","author":"Khalifa","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115245_bb1110","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.actbio.2025.04.030","article-title":"Endogenous nanoplatforms for tumor photoimmunotherapy: hypoxia modulation and STING pathway activation","volume":"199","author":"Yang","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115245_bb1115","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006235","article-title":"Adding liposomal doxorubicin enhances the abscopal effect induced by radiation\/\u03b1PD1 therapy depending on tumor cell mitochondrial DNA and cGAS\/STING","volume":"11","author":"Wang","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115245_bb1120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1074477","article-title":"Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1125","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s12276-025-01457-6","article-title":"Cholesterol biosynthesis induced by radiotherapy inhibits cGAS\u2013STING activation and contributes to colorectal cancer treatment resistance","volume":"57","author":"Zhu","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115245_bb1130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41392-025-02140-y","article-title":"Phototherapy in cancer treatment: strategies and challenges","volume":"10","author":"Cai","year":"2025","journal-title":"Sign. Transd. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115245_bb1135","article-title":"pH\/NIR dual-responsive implantable patch for combined photothermal and chemotherapy of tumors","volume":"11","author":"Sun","year":"2026","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.jconrel.2026.115245_bb1140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/cac2.12405","article-title":"Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence","volume":"43","author":"Hao","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jconrel.2026.115245_bb1145","article-title":"The STING1 network regulates autophagy and cell death","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115245_bb1150","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.apsb.2024.02.006","article-title":"Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115245_bb1155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1383000","article-title":"Harnessing the cGAS-STING pathway to potentiate radiation therapy: current approaches and future directions","volume":"15","author":"Colangelo","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1160","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1038\/s41375-023-02055-z","article-title":"STING activation in TET2-mutated hematopoietic stem\/progenitor cells contributes to the increased self-renewal and neoplastic transformation","volume":"37","author":"Xie","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2026.115245_bb1165","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000282","article-title":"Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma","volume":"8","author":"Wang-Bishop","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115245_bb1170","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/intimm\/dxac012","article-title":"Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation","volume":"34","author":"Temizoz","year":"2022","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1175","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4049\/jimmunol.2000007","article-title":"Adoptive T cell therapy with IL-12\u2013preconditioned low-avidity T cells prevents exhaustion and results in enhanced T cell activation, enhanced tumor clearance, and decreased risk for autoimmunity","volume":"205","author":"Tucker","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1180","article-title":"Nanoparticle approaches for manipulating cytokine delivery and neutralization","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1185","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202500296","article-title":"STING agonists and how to reach their full potential in cancer immunotherapy","volume":"12","author":"Gehrcken","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb1190","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/molecules21121715","article-title":"Recent advances in stimuli-responsive release function drug delivery systems for tumor treatment","volume":"21","author":"Ding","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2026.115245_bb1195","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/acsnano.3c11464","article-title":"Dual-responsive nanomedicine activates programmed antitumor immunity through targeting lymphatic system","volume":"18","author":"Xiao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122067","article-title":"A hierarchical tumor-targeting strategy for eliciting potent antitumor immunity against triple negative breast cancer","volume":"296","author":"Lin","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115245_bb1205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jconrel.2023.03.047","article-title":"Unlocking the promise of systemic STING agonist for cancer immunotherapy","volume":"357","author":"Sun","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb1210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imr.13281","article-title":"Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross-priming","volume":"321","author":"Luri-Rey","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2026.115245_bb1215","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/imr.13301","article-title":"Decoding immunogenic cell death from a dendritic cell perspective","volume":"321","author":"Janssens","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2026.115245_bb1220","first-page":"2192","article-title":"Enhanced tumor immunotherapy by triple amplification effects of nanomedicine on the STING signaling pathway in dendritic cells","volume":"14","author":"Wang","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115245_bb1225","article-title":"A review on drug delivery system for tumor therapy","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1230","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1042\/CS20220531","article-title":"M1\/M2 macrophages and their overlaps \u2013 myth or reality?","volume":"137","author":"Strizova","year":"2023","journal-title":"Clin. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb1235","doi-asserted-by":"crossref","first-page":"18100","DOI":"10.1021\/acsnano.1c06707","article-title":"Precise delivery of Nanomedicines to M2 macrophages by combining \u201ceat me\/don\u2019t eat me\u201d signals and its anticancer application","volume":"15","author":"Tang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115245_bb1240","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002499","article-title":"Chemically engineered immune cell-derived microrobots and biomimetic nanoparticles: emerging biodiagnostic and therapeutic tools","volume":"8","author":"Jahromi","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb1245","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12951-022-01582-8","article-title":"Nanocarriers for effective delivery: modulation of innate immunity for the management of infections and the associated complications","volume":"20","author":"Ko","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1250","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jconrel.2015.08.050","article-title":"Stimuli-responsive nanoparticles for targeting the tumor microenvironment","volume":"219","author":"Du","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb1255","doi-asserted-by":"crossref","first-page":"538","DOI":"10.7150\/thno.16684","article-title":"Current multistage drug delivery systems based on the tumor microenvironment","volume":"7","author":"Chen","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115245_bb1260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1714249","article-title":"Stimuli-responsive nanoplatforms for precision activation of the STING pathway in cancer immunotherapy","volume":"17","author":"Bi","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1265","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1158\/0008-5472.CAN-23-3511","article-title":"Ionizable STING-activating nanoadjuvants enhance tumor immunogenicity and potentiate immunotherapy efficacy in solid tumors","volume":"84","author":"Xian","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb1270","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13046-025-03555-9","article-title":"Bridging innate and adaptive tumor immunity: cGAS\u2013STING pathway activation to potentiate immune checkpoint blockade","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb1275","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001182","article-title":"Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity","volume":"8","author":"Lemos","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115245_bb1280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.iotech.2019.10.001","article-title":"Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors","volume":"3","author":"Agrawal","year":"2019","journal-title":"Immunooncol. Technol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1285","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.apsb.2020.03.001","article-title":"Small molecules targeting the innate immune cGAS\u2013STING\u2013TBK1 signaling pathway","volume":"10","author":"Ding","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115245_bb1290","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/ITT.S253581","article-title":"Immune-checkpoint inhibitors combinations in metastatic NSCLC: new options on the horizon?","volume":"10","author":"Passiglia","year":"2021","journal-title":"Immuno. Targets Ther."},{"key":"10.1016\/j.jconrel.2026.115245_bb1295","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.3390\/jcm9103323","article-title":"Challenges and opportunities in the clinical development of STING agonists for cancer immunotherapy","volume":"9","author":"Motedayen Aval","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2026.115245_bb1300","doi-asserted-by":"crossref","DOI":"10.1172\/JCI204547","article-title":"Therapeutic targeting of the cGAS-STING pathway in human disease","volume":"136","author":"Mahajan","year":"2026","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115245_bb1305","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102530","article-title":"Conjugated STING agonists","volume":"36","author":"Qu","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.115245_bb1310","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1158\/1078-0432.CCR-24-2824","article-title":"Intratumoral or subcutaneous MK-2118, a noncyclic dinucleotide STING agonist, with or without Pembrolizumab, for advanced or metastatic solid tumors or lymphomas","volume":"31","author":"Luke","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb1315","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/colloids10010007","article-title":"Lipid-based colloidal nanocarriers for site-specific drug delivery","volume":"10","author":"Shameli","year":"2026","journal-title":"Colloids Interfaces"},{"key":"10.1016\/j.jconrel.2026.115245_bb1320","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJN.S504629","article-title":"Design of pH-responsive nanomaterials based on the tumor microenvironment","volume":"20","author":"Liu","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115245_bb1325","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/nano16030172","article-title":"Nanomaterial-enabled modulation of tumor-associated macrophages and dendritic cells to enhance cancer immunotherapy","volume":"16","author":"Thamizhchelvan","year":"2026","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2026.115245_bb1330","doi-asserted-by":"crossref","first-page":"834","DOI":"10.30574\/ijsra.2025.14.3.0730","article-title":"Regulatory challenges in complex generics: a focus on liposomal and nanoparticulate drug products","volume":"14","author":"Kateregga","year":"2025","journal-title":"Int. J. Sci. Res. Arch."},{"key":"10.1016\/j.jconrel.2026.115245_bb1335","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/cells14060447","article-title":"Chromosomal instability is associated with cGAS\u2013STING activation in EGFR-TKI refractory non-small-cell lung cancer","volume":"14","author":"Yonesaka","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115245_bb1340","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/life15081171","article-title":"Association of TMEM173\/STING1 gene variants with severe COVID-19 among fully vaccinated vs. non-vaccinated individuals","volume":"15","author":"V\u00e1zquez-Coto","year":"2025","journal-title":"Life"},{"key":"10.1016\/j.jconrel.2026.115245_bb1345","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.molcel.2022.12.023","article-title":"p53 engages the cGAS\/STING cytosolic DNA sensing pathway for tumor suppression","volume":"83","author":"Ghosh","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2026.115245_bb1350","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41401-025-01639-y","article-title":"DNMT inhibition epigenetically restores the cGAS-STING pathway and activates RIG-I\/MDA5-MAVS to enhance antitumor immunity","volume":"47","author":"Tu","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2026.115245_bb1355","series-title":"Regular and Young Investigator Award Abstracts","article-title":"1160 STING signaling compensates for mutation burden-low tumors to stimulate the immune response","author":"Tan","year":"2022"},{"key":"10.1016\/j.jconrel.2026.115245_bb1360","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1984677","article-title":"Trial watch: intratumoral immunotherapy","volume":"10","author":"Humeau","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jconrel.2026.115245_bb1365","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001800","article-title":"Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy","volume":"9","author":"Mu\u00f1oz","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115245_bb1370","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jvir.2025.09.012","article-title":"Using controlled drug delivery systems to increase the effectiveness of intratumoral immuno-oncology","volume":"36","author":"Sharma","year":"2025","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1375","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-026-02130-3","article-title":"AND logic nanoparticle for precision immunotherapy of metastatic cancers","author":"Ye","year":"2026","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1380","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102727","article-title":"J-aggregated indocyanine green-loaded exosomes enable photoactivatable cytoplasmic delivery of STING agonist for targeted pancreatic cancer immunotherapy","volume":"62","author":"Li","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115245_bb1385","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114238","article-title":"SitoC7A-modified lipid nanoparticles for integrated mRNA delivery and targeted STING activation","volume":"387","author":"Qiao","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb1390","first-page":"9136","article-title":"Projecting MIW815 (ADU-S100) human tumor PK after intratumoral injection using a translational modeling approach combining preclinical and clinical data","author":"M\u00e9lanie","year":"2019","journal-title":"PAGE"},{"key":"10.1016\/j.jconrel.2026.115245_bb1395","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1163432","article-title":"Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager","volume":"14","author":"Anbari","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115245_bb1400","doi-asserted-by":"crossref","first-page":"16274","DOI":"10.3390\/ijms242216274","article-title":"Tumor regression upon intratumoral and subcutaneous dosing of the STING agonist ALG-031048 in mouse efficacy models","volume":"24","author":"Jekle","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb1405","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jconrel.2023.03.047","article-title":"Unlocking the promise of systemic STING agonist for cancer immunotherapy","volume":"357","author":"Sun","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115245_bb1410","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41467-025-55847-5","article-title":"Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer","volume":"16","author":"Captier","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115245_bb1415","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e14247","article-title":"An emerging era in manufacturing of drug delivery systems: nanofabrication techniques","volume":"9","author":"Pingale","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jconrel.2026.115245_bb1420","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/ijms27031387","article-title":"Emerging Nanomedicine strategies for chronic disease management based on chitosan","volume":"27","author":"P\u00e9rez-Pacheco","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb1425","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/pharmaceutics17121613","article-title":"PLGA-based co-delivery nanoformulations: overview, strategies, and recent advances","volume":"17","author":"Stevanovi\u0107","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115245_bb1430","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.2147\/IJN.S139450","article-title":"CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties","volume":"14","author":"Mayer","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115245_bb1435","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s11095-025-03951-y","article-title":"Co-encapsulation of an AKT inhibitor enhances the tumor-cell selectivity of STING agonists in co-delivery liposomes","volume":"42","author":"Ge","year":"2025","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.115245_bb1440","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1038\/s41467-025-60927-7","article-title":"Engineering STING nanoadjuvants for spatiotemporally-tailored innate immunity stimulation and cancer vaccination therapy","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115245_bb1445","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202514516","article-title":"Dual-locked polymeric STING nano-agonist\/sonosensitizer augments spatiotemporally controlled cancer sono-immunotherapy","volume":"64","author":"Jia","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115245_bb1450","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejpb.2021.03.004","article-title":"Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery","volume":"163","author":"Mildner","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115245_bb1455","article-title":"A purely biomanufactured system for delivering nanoparticles and STING agonists","volume":"12","author":"Li","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115245_bb1460","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2217\/nnm-2022-0069","article-title":"Quality-by-design-based engineered liposomal nanomedicines to treat cancer: an in-depth analysis","volume":"17","author":"Kapoor","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115245_bb1465","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.drudis.2018.12.002","article-title":"Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products","volume":"24","author":"Beg","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.115245_bb1470","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102206","article-title":"Using the quality by design (QbD) approach to optimize formulations of lipid nanoparticles and nanoemulsions: a review","volume":"28","author":"Cunha","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2026.115245_bb1475","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-025-01079-w","article-title":"Rethinking pharmaceutical industry with quality by design: application in research, development, manufacturing, and quality assurance","volume":"27","author":"Duarte","year":"2025","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.115245_bb1480","article-title":"Temporally programmed STING nanoadjuvant delivery unlocks synergistic chemotherapy- induced antitumor immunity","volume":"11","author":"Yang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115245_bb1485","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202502315","article-title":"Nanoparticle therapeutics in clinical perspective: classification, marketed products, and regulatory landscape","volume":"21","author":"Desai","year":"2025","journal-title":"Small"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:05:48Z","timestamp":1790211948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926006498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":297,"alternative-id":["S0168365926006498"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115245","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STING-targeted nanomedicine in combination cancer immunotherapy: From rational design to formulation engineering to clinical translation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115245"}}